[autismo-biologia] Ricerca farmacologica preclinica: il sistema cannabinoide

daniela a autismo33.it daniela a autismo33.it
Gio 19 Ott 2017 11:56:43 CEST


Al convegno della Societá Italiana di Farmacologia del 25 – 28 ottobre pv
a Rimini si parlerá di  nuove prospettive terapeutiche per l’autismo
incentrate soprattutto sul sistema cannabinoide

http://congresso.sifweb.org/

16.30-18.30 SYMPOSIUM THE ENDOCANNABINOID SYSTEM AND AUTISM SPECTRUM
DISORDERS

Chairpersons: Daniela Parolaro (Milan) - Marie Woolley (London - UK)

Targeting anandamide metabolism rescues autistic-like symptoms in rats
prenatally exposed to valproic acid Viviana Trezza (Rome)

The non-psychotropic plant cannabinoid cannabidivarin ameliorates Rett
syndrome-like phenotype in methyl CpG binding protein 2 (MeCP2) mutant
mice Erica Zamberletti (Busto Arsizio)

The endocannabinoid system as therapeutic target for fragile X syndrome
and other cognitive disorders Rafael Maldonado (Barcelona – Spain)

 Endocannabinoid system dysregulation drives inflammatory state and human
immune system cell alterations in autism spectrum disorders Dario
Siniscalco (Naples)


Changes in the endocannabinoid system underlie the altered social behavior
observed in a rat model of autism spectrum disorders Melancia F., Servadio
M., Schiavi S., Manduca A., Cartocci V., Pallottini V., Trezza V

Chronic cannabidivarin administration rescues autism-like behaviors
induced by prenatal valproic acid exposure in male offspring Gabaglio M.,
Zamberletti E., Piscitelli F., Rubino T., Di Marzo V., Parolaro D


Behavioral and metabolic characterization of a mouse model of autism
spectrum disorder and a possible therapeutic effect of
palmitoylethanolamide Cristiano C., Coretti L., Lama A., Russo R., Mattace
Raso G., Lembo F., Chiariotti L., Meli R., Calignano A.

http://www.archiviosif.org/eventi/2017/sif_38_cong_naz_rimini_2017_prog.pdf

  Daniela Mariani Cerati






Maggiori informazioni sulla lista autismo-biologia